Royal Bank of Canada’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-294
| Closed | -$15K | – | 7534 |
|
|
2020
Q3 | $15K | Sell |
294
-61,926
| -100% | -$2.56M | ﹤0.01% | 5810 |
|
|
2020
Q2 | $2.07M | Buy |
62,220
+21,571
| +53% | +$687K | ﹤0.01% | 2583 |
|
|
2020
Q1 | $1.11M | Buy |
40,649
+29,651
| +270% | +$826K | ﹤0.01% | 2951 |
|
|
2019
Q4 | $217K | Buy |
10,998
+10,805
| +5,598% | +$173K | ﹤0.01% | 4587 |
|
|
2019
Q3 | $3K | Buy |
193
+149
| +339% | +$1.8K | ﹤0.01% | 6248 |
|
|
2019
Q2 | $1K | Hold |
44
| – | – | ﹤0.01% | 6789 |
|
|
2019
Q1 | $1K | Hold |
44
| – | – | ﹤0.01% | 6722 |
|
|
2018
Q4 | $0 | Sell |
44
-34,021
| -100% | -$473K | ﹤0.01% | 7367 |
|
|
2018
Q3 | $896K | Buy |
34,065
+3,902
| +13% | +$105K | ﹤0.01% | 3453 |
|
|
2018
Q2 | $616K | Buy |
30,163
+1,082
| +4% | +$23.2K | ﹤0.01% | 3630 |
|
|
2018
Q1 | $528K | Buy |
29,081
+559
| +2% | +$9.32K | ﹤0.01% | 3667 |
|
|
2017
Q4 | $398K | Sell |
28,522
-6,650
| -19% | -$89.9K | ﹤0.01% | 3941 |
|
|
2017
Q3 | $650K | Buy |
35,172
+7,558
| +27% | +$126K | ﹤0.01% | 3594 |
|
|
2017
Q2 | $467K | Sell |
27,614
-2,001
| -7% | -$30.5K | ﹤0.01% | 3705 |
|
|
2017
Q1 | $396K | Sell |
29,615
-2,780
| -9% | -$43.5K | ﹤0.01% | 3824 |
|
|
2016
Q4 | $488K | Buy |
32,395
+7,022
| +28% | +$92.7K | ﹤0.01% | 3767 |
|
|
2016
Q3 | $297K | Sell |
25,373
-206
| -0.8% | -$2.42K | ﹤0.01% | 4148 |
|
|
2016
Q2 | $276K | Buy |
25,579
+3,375
| +15% | +$34.8K | ﹤0.01% | 4174 |
|
|
2016
Q1 | $206K | Buy |
22,204
+13,548
| +157% | +$146K | ﹤0.01% | 4354 |
|
|
2015
Q4 | $128K | Sell |
8,656
-854
| -9% | -$14.3K | ﹤0.01% | 4800 |
|
|
2015
Q3 | $157K | Sell |
9,510
-23,600
| -71% | -$483K | ﹤0.01% | 4498 |
|
|
2015
Q2 | $756K | Buy |
33,110
+27,244
| +464% | +$543K | ﹤0.01% | 3177 |
|
|
2015
Q1 | $89K | Sell |
5,866
-1,501
| -20% | -$19.5K | ﹤0.01% | 4676 |
|
|
2014
Q4 | $88K | Buy |
7,367
+2,955
| +67% | +$33.8K | ﹤0.01% | 4793 |
|
|
2014
Q3 | $50K | Sell |
4,412
-93
| -2% | -$1.06K | ﹤0.01% | 4948 |
|
|
2014
Q2 | $54K | Buy |
4,505
+615
| +16% | +$7.26K | ﹤0.01% | 4806 |
|
|
2014
Q1 | $45K | Sell |
3,890
-119
| -3% | -$2.02K | ﹤0.01% | 4900 |
|
|
2013
Q4 | $71K | Buy |
4,009
+3,613
| +912% | +$60.7K | ﹤0.01% | 4752 |
|
|
2013
Q3 | $6K | Buy |
+396
| New | +$6.06K | ﹤0.01% | 5596 |
|
Royal Bank of Canada's MNTA Position: Q4 2020 in Review
Royal Bank of Canada sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 294 shares — an estimated $15K sold.
Royal Bank of Canada first reported a position in MNTA in Q3 2013 and held it in 29 quarters. The position peaked at $2.07M in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Royal Bank of Canada reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Royal Bank of Canada sold 294 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $15K.
- Royal Bank of Canada first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 29 quarters.
- Royal Bank of Canada's Momenta Pharmaceuticals, Inc. position peaked at $2.07M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Royal Bank of Canada's 13F filing for Q4 2020, filed 16 Feb 2021.